Novo Nordisk pays $26.7 million to settle US lawsuits<\/a><\/span> (2011)<\/p>","protected":false},"excerpt":{"rendered":"Lars Rebien S\u00f8rensen, presidente e CEO di Novo Nordisk, \u00e8 stato nominato miglior CEO del mondo, nella classifica 2015 stilata dalla prestigiosa rivista americana Harvard Business Review. La scelta \u00e8 stata motivata dai risultati ottenuti da Rebien S\u00f8rensen alla guida dell\u2019azienda farmaceutica danese sia per gli aspetti finanziari sia per le performance in ambito sociale, …<\/p>","protected":false},"author":4,"featured_media":645,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22202","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/22202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=22202"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/22202\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/645"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=22202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=22202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=22202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"http:\/\/img.borsen.dk\/img\/cms\/tuksi4\/media\/nyheder\/16_9_large\/10\/250810_16_9_large_649.jpg\")
The choice was motivated by the results obtained by Rebien S\u00f8rensen at the helm of the Danish pharmaceutical company in terms of both financial aspects and performance in the social, environmental and governance fields. In particular, according to the Harvard Business Review, the recognition is motivated both by the strategic decision taken by the company to focus on the treatment of diabetes, a disease experiencing dramatic growth in the world, and by the great attention that the company dedicates to social and environmental issues.<\/p>\n![\"\"](\"https:\/\/hbr.org\/resources\/images\/article_assets\/2015\/10\/oct15-012-100-topceos_b-383x215.png\")
financial results, but also considering that our company is able to achieve its objectives by respecting the environment and always working in a socially responsible and sustainable way\u00bb.<\/p>\n